Article
Although the mandatory compliance date for implementation is October 1, 2013, you'll need to accomplish much between now and then to make documentation and diagnosis reporting as seamless as possible.
UGN-101 associated with favorable long-term durability in low-grade UTUC
Episode 3 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management
Danish Medicines Agency approves PSMA-PET imaging product for prostate cancer
Episode 2 Podcast: Identifying Patients with Intermediate Risk in NMIBC
Trends in urology: Arpeet Shah, MD, on challenges and opportunities in 2025
FDA grants 510(k) clearance to AI-powered prostate cancer diagnostic